WPI 3630 (Hydromorphone Hydrochloride Extended-Release 16 mg)
Pill with imprint WPI 3630 is Yellow, Round and has been identified as Hydromorphone hydrochloride extended-release 16 mg. It is supplied by Watson Laboratories, Inc..
Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 16 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3630
Hydromorphone hydrochloride extended-release
- Imprint:
- WPI 3630
- Strength:
- 16 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-3630
More about hydromorphone
- Hydromorphone Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 370 Reviews
- Drug class: narcotic analgesics
Consumer resources
- Hydromorphone
- Hydromorphone injection
- Hydromorphone rectal
- Hydromorphone Extended-Release Tablets
- Hydromorphone Tablets
- ... +4 more
Other brands: Dilaudid, Exalgo, Dilaudid-HP, Palladone
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
